StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)

Analysts at StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZGet Free Report) in a report released on Friday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Price Performance

Shares of ENZ stock opened at $1.04 on Friday. The business’s 50-day moving average price is $1.13 and its 200-day moving average price is $1.12. Enzo Biochem has a 12 month low of $0.99 and a 12 month high of $1.50.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ENZ. BBR Partners LLC bought a new position in Enzo Biochem during the 3rd quarter valued at $112,000. Renaissance Technologies LLC lifted its holdings in Enzo Biochem by 2.6% during the second quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after acquiring an additional 64,417 shares during the period. XTX Topco Ltd lifted its holdings in Enzo Biochem by 94.5% during the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after acquiring an additional 13,735 shares during the period. Finally, Geode Capital Management LLC grew its stake in Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 11,742 shares during the period. 36.90% of the stock is currently owned by institutional investors and hedge funds.

Enzo Biochem Company Profile

(Get Free Report)

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.

Featured Articles

Receive News & Ratings for Enzo Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzo Biochem and related companies with MarketBeat.com's FREE daily email newsletter.